Neuroone Medical Technologies (NMTC) Total Current Liabilities (2010 - 2026)

Neuroone Medical Technologies has disclosed Total Current Liabilities across 17 years of filings, most recently posting $1.7 million for Q1 2026.

• Quarterly Total Current Liabilities fell 4.19% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 4.19% YoY) and the FY2025 annual result came in at $2.3 million, up 4.06% from the prior year.
• Total Current Liabilities grew to $1.7 million in Q1 2026, from $1.3 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $3.1 million in Q3 2022 and bottomed at $810231.0 in Q1 2022.
• The 5-year median for Total Current Liabilities is $1.6 million (2024), against an average of $1.6 million.
• Year-over-year, Total Current Liabilities soared 162.22% in 2022 and sank 42.15% in 2023.
• Neuroone Medical Technologies' Total Current Liabilities stood at $1.3 million in 2022, then climbed by 3.63% to $1.4 million in 2023, then advanced by 13.57% to $1.6 million in 2024, then declined by 19.89% to $1.3 million in 2025, then surged by 34.25% to $1.7 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $1.7 million, $1.3 million, and $2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.